Cervical Cancer Represents Up to 29% of India's Cancer Burden: Expert Stresses Pap Test Importance
Cervical Cancer 29% of India Cancers: Pap Test Vital

Cervical Cancer Accounts for Up to 29% of All Cancers in India

India faces a significant burden from cervical cancer, with this disease representing between 6% and 29% of all cancer cases nationwide. According to Dr. Sahana K P, Consultant in Obstetrics, Gynecology, and Reproductive Medicine at Apollo Hospitals, Sheshadripuram, Bengaluru, there is an increased emphasis on cancer screening. "If there is one medical area where early detection genuinely saves lives, it is in cancer screening," she states. "Cervical cancer now ranks as the second most common cancer in India. Fortunately, it is one of the few cancers with a reliable, easily reproducible, cost-effective screening test that offers good sensitivity and specificity rates."

The Pap Test Identifies Early Lesions and Prevents Cervical Cancer

Dr. Sahana K P explains that 70-80% of cervical cancer cases originate from HPV infections, particularly high-risk strains. "If a patient contracts a high-risk HPV strain, she may remain asymptomatic for many years before potentially developing cervical cancer or a precancerous lesion much later," she notes. "Therefore, protecting oneself from HPV infection and diagnosing early lesions with a Pap test forms the cornerstone of cervical cancer prevention."

The Papnicolaou test, commonly known as the Pap test, originated in the 1940s when Dr. Papnicolaou discovered that examining cervical cells under a microscope could diagnose cancerous changes at an early stage. This breakthrough provided a window to treat pre-cancerous and early-stage cervical cancer with minimal, effective interventions, ensuring high cure rates. During the 1980s, the method gained further popularity with the development of newer cytology techniques that combined HPV DNA testing with cell cytology study in a single test.

Methods of Conducting a Pap Smear

There are two primary methods for performing a Pap smear:

  • Conventional Method: This involves taking cell scrapings from the endocervix and posterior vaginal wall, placing them on a slide, and fixing them with a fixative.
  • Liquid-Based Cytology (LBC): In this superior technique, cells collected with a specific cytobrush are placed in a liquid-based medium and sent to a lab for analysis. LBC also helps determine the presence and load of HPV DNA in the same sample, which is crucial for guiding treatment and follow-up assessments.

Debunking Common Myths About Pap Tests

One of the most prevalent misconceptions among women is the belief that if they are asymptomatic or lack risk factors, they do not need a Pap smear. However, Dr. Sahana clarifies that the Pap smear is a fundamental screening test designed for the general population of asymptomatic women to identify those with precancerous cervical changes and offer early diagnosis and treatment.

Screening guidelines recommend:

  1. Starting Pap smears at the onset of sexual activity, typically by age 21.
  2. If results are negative, repeating the test every 3 years until age 30.
  3. Between ages 30 and 65, undergoing a Pap test every 3 years or a Pap test combined with high-risk HPV DNA testing every 5 years.
  4. Beyond age 65, consulting a gynecologist to determine the frequency, such as every 3 or 5 years.

How the Pap Test Is Performed

The test involves a basic pelvic examination using speculums, during which the gynecologist collects cells from the cervix and processes them using either the conventional or LBC technique. The sample is then sent to a lab for analysis and interpretation by a pathologist.

Important preparation notes include:

  • Avoid using tampons or menstrual cups on the day of the test.
  • Preferably schedule the test when not menstruating.
  • Refrain from using douches and menstrual products for up to two days before the test.

Results are categorized as positive or negative. Contrary to common belief, a screen-positive result is not reassuring; it indicates abnormal cells requiring further evaluation with colposcopy or biopsy. A screen-negative result means no abnormal cells were found, providing reassurance and allowing for retesting after 3-5 years.

The Bottom Line: A Lifesaving Test

In summary, the Pap test is a simple, effective, and lifesaving procedure. In today's era, with the growing burden of cancer, this test can reduce the risk of cervical cancer by an impressive 83%. If you have never undergone a Pap test, now is the time to visit your nearest well-woman clinic. Prioritizing this test demonstrates a commitment to long-term health and well-being, offering peace of mind through a negative screening report that brings unmatched happiness and reassurance.